ThyroSeq® Cancer Risk Classifier (CRC) Sample Report

The results of the ThyroSeq® v3 CRC test are reported in a user-friendly format that contains:

• Report Summary with an assessed risk of cancer recurrence based on detected molecular alterations in the patient's FNA sample from cytologically malignant (Bethesda VI) nodule or resected thyroid cancer

• Result Interpretation section providing more information on types of genetic alterations detected, their association with a specific type of cancer and with the risk of cancer recurrence, suggested potential clinical management, including selection of targeted therapy
• Detailed Results section lists all alterations detected including mutation allele frequency and fusion gene partners